XML 20 R8.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Net Cash Provided by (Used in) Operating Activities [Abstract]    
Net income $ 447,990 $ 436,924
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Provisions for credit losses 409,505 256,691
Income tax expense 146,006 130,798
Amortization of brokered deposit placement fee 14,881 12,292
Amortization of Secured Borrowing Facility upfront fee 2,159 838
Amortization of deferred loan origination costs and loan premium/(discounts), net 20,127 9,750
Net amortization of discount on investments 4,255 1,312
Unrealized gain on investments (2,100) 0
(Increase) reduction in tax indemnification receivable (698) 981
Depreciation of premises and equipment 11,386 10,850
Stock-based compensation expense 30,253 24,841
Unrealized gains on derivatives and hedging activities, net (21,862) (24,957)
Gains on sales of loans, net (238,562) 0
Gain on sale of Upromise subsidiary, net (11,331) 0
Other adjustments to net income, net 5,389 (2,447)
Changes in operating assets and liabilities:    
Increase in accrued interest receivable (668,103) (719,555)
Increase in non-marketable securities 0 (10,700)
Increase in other interest-earning assets (1,244) (47,513)
Decrease in tax indemnification receivable 0 0
Increase in other assets (46,194) (10,274)
Decrease in income taxes payable, net (243,851) (184,991)
Increase in accrued interest payable 38 21,831
Decrease in Upromise member accounts due to sale (193,840) 0
Increase in other liabilities 126,645 15,928
Total adjustments (657,141) (514,325)
Total net cash used in operating activities (209,151) (77,401)
Investing activities    
Loans acquired and originated (4,736,304) (5,335,986)
Net proceeds from sales of loans held for investment 3,875,984 0
Proceeds from claim payments 22,563 31,474
Net decrease in loans held for investment 2,954,660 2,992,844
Purchases of available-for-sale securities (1,897,511) (305,872)
Proceeds from sales and maturities of available-for-sale securities 376,580 32,282
Proceeds from sale of Upromise subsidiary, net 16,922 0
Total net cash provided by (used in) investing activities 612,894 (2,585,258)
Financing activities    
Brokered deposit placement fee (4,810) (19,799)
Net (decrease) increase in certificates of deposit (1,802,541) 2,682,850
Net increase in other deposits 501,843 911,985
Borrowings collateralized by loans in securitization trusts - issued 1,337,543 1,105,594
Borrowings collateralized by loans in securitization trusts - repaid (749,300) (793,062)
Borrowings under Secured Borrowing Facility 0 297,800
Repayment of borrowings under Secured Borrowing Facility (289,230) 0
Fees paid on Secured Borrowing Facility (3,251) (1,116)
Common stock dividends paid (35,097) (38,485)
Preferred stock dividends paid (8,000) (12,952)
Common stock repurchased (558,167) (157,597)
Net cash (used in) provided by financing activities (1,611,010) 3,975,218
Net (decrease) increase in cash, cash equivalents and restricted cash (1,207,267) 1,312,559
Cash, cash equivalents and restricted cash at beginning of period 5,720,760 2,681,895
Cash, cash equivalents and restricted cash at end of period 4,513,493 3,994,454
Cash disbursements made for:    
Interest 402,151 489,599
Income taxes paid 248,121 185,138
Income taxes refunded (4,024) (853)
Reconciliation of the Consolidated Statements of Cash Flows to the Consolidated Balance Sheets:    
Total cash, cash equivalents and restricted cash $ 4,513,493 $ 3,994,454